Compare GSK Consumer with REI AGRO. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs REI AGRO. - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER REI AGRO. GSK CONSUMER/
REI AGRO.
 
P/E (TTM) x 39.1 -0.0 - View Chart
P/BV x 11.0 - - View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 GSK CONSUMER   REI AGRO.
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
REI AGRO.
Mar-16
GSK CONSUMER/
REI AGRO.
5-Yr Chart
Click to enlarge
High Rs7,8191 781,940.0%   
Low Rs5,832NA 1,457,925.0%   
Sales per share (Unadj.) Rs1,136.95.4 20,873.4%  
Earnings per share (Unadj.) Rs233.7-11.2 -2,080.1%  
Cash flow per share (Unadj.) Rs248.1-10.1 -2,446.9%  
Dividends per share (Unadj.) Rs105.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs973.5-38.8 -2,510.8%  
Shares outstanding (eoy) m42.06957.98 4.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.00.1 4,671.4%   
Avg P/E ratio x29.2-0.1 -46,876.7%  
P/CF ratio (eoy) x27.5-0.1 -39,849.1%  
Price / Book Value ratio x7.00 -38,835.7%  
Dividend payout %44.90-   
Avg Mkt Cap Rs m287,083671 42,810.8%   
No. of employees `0003.8NA-   
Total wages/salary Rs m6,44654 12,004.1%   
Avg. sales/employee Rs Th12,440.2NM-  
Avg. wages/employee Rs Th1,677.0NM-  
Avg. net profit/employee Rs Th2,556.7NM-  
INCOME DATA
Net Sales Rs m47,8205,218 916.4%  
Other income Rs m4,3269 50,302.3%   
Total revenues Rs m52,1465,227 997.7%   
Gross profit Rs m11,410-7,470 -152.7%  
Depreciation Rs m6061,050 57.7%   
Interest Rs m81,854 0.4%   
Profit before tax Rs m15,123-10,365 -145.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,002 0.0%   
Tax Rs m5,295-606 -873.7%   
Profit after tax Rs m9,828-10,761 -91.3%  
Gross profit margin %23.9-143.2 -16.7%  
Effective tax rate %35.05.8 598.9%   
Net profit margin %20.6-206.2 -10.0%  
BALANCE SHEET DATA
Current assets Rs m52,6743,387 1,555.2%   
Current liabilities Rs m18,14069,182 26.2%   
Net working cap to sales %72.2-1,260.9 -5.7%  
Current ratio x2.90 5,931.4%  
Inventory Days Days365 713.4%  
Debtors Days Days29209 14.1%  
Net fixed assets Rs m4,79823,246 20.6%   
Share capital Rs m4211,358 31.0%   
"Free" reserves Rs m40,527-40,735 -99.5%   
Net worth Rs m40,947-37,145 -110.2%   
Long term debt Rs m02 0.0%   
Total assets Rs m60,68130,690 197.7%  
Interest coverage x1,939.8-4.6 -42,255.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.2 463.5%   
Return on assets %16.2-29.0 -55.8%  
Return on equity %24.029.0 82.8%  
Return on capital %37.025.6 144.3%  
Exports to sales %014.5 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA755 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171755 419.9%   
Fx outflow Rs m1,7702 81,195.0%   
Net fx Rs m1,401753 186.0%   
CASH FLOW
From Operations Rs m6,711903 742.9%  
From Investments Rs m-3,3518 -40,368.7%  
From Financial Activity Rs m-3,768-1,553 242.6%  
Net Cashflow Rs m-408-642 63.6%  

Share Holding

Indian Promoters % 0.0 37.4 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 0.2 421.1%  
FIIs % 12.0 22.2 54.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 40.2 36.8%  
Shareholders   26,457 72,487 36.5%  
Pledged promoter(s) holding % 0.0 18.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   MCLEOD RUSSEL  UNITED SPIRITS  GOODRICKE  VENKYS (I) LIMITED  KWALITY  

Compare GSK CONSUMER With:   NESTLE (Switz.)  TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  



Today's Market

Sensex Opens Flat; Banking & FMCG Stocks Under Pressure(09:30 am)

Asian stock markets are lower today as investors adjusted risk exposure heading into the US election and as a deadline for Washington to pass an economic stimulus bill approached.

Related Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY19); Net Profit Up 34.9% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 34.9% YoY). Sales on the other hand came in at Rs 13 bn (up 9.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Feb 18, 2019 | Updated on Feb 18, 2019

For the quarter ended December 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 35.1% YoY). Sales on the other hand came in at Rs 11 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Oct 9, 2020

How I picked an exciting stock using trends from both the commodity and equity markets.

The 'Seedhi Baat, No Bakwaas' View on ITC(Profit Hunter)

Oct 12, 2020

Is ITC an investment or a speculation at current levels?

How to Shortlist the Best Stocks for Trading(Fast Profits Daily)

Oct 7, 2020

In this video, I'll show you how to identify a confluence of factors in the market which will point you to the best stocks to trade.

The Inflection Point for Defence Stocks is Getting Closer(Profit Hunter)

Oct 9, 2020

Few Indian defence companies could use their engineering capabilities to eventually become global leaders.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS